Many Korean pharmaceutical companies are struggling to finalize their business plans for the new year, an industry survey found recently.
A new drug-pricing reform has led many companies to say they have no plans to jump into a new business next year, raising fears that development of future growth engines will slow.
According to industry observers, the cash reward plan is not good for ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.